| Patents for C08B 37 - Preparation of polysaccharides not provided for in groups; Derivatives thereof (24,467) |
|---|
| 04/17/2003 | WO2003000305A3 Polysaccharide biomaterials and methods of use thereof |
| 04/17/2003 | WO2002083700A3 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 04/17/2003 | US20030073820 Hemoglobin conjugate for use in the synthetic blood |
| 04/17/2003 | DE10145338C1 Verfahren zum Abtrennen von Hemicellulosen aus hemicellulosehaltiger Biomasse A method for separating hemicelluloses from hemicellulose-containing biomass |
| 04/16/2003 | EP1301543A1 Method for preparing galactomannan oligomers |
| 04/16/2003 | EP1301542A2 Process for obtaining bio-functional fractions from biomass |
| 04/16/2003 | EP1301192A1 Use of polysulphated cyclodextrins for treating osteoarthritis |
| 04/16/2003 | EP0882068B1 Polyhydroxy polymers substituted with styryl ether groups and gels and surfaces prepared from them |
| 04/16/2003 | CN1411471A Macroporous chitosan beads and preparation method thereof |
| 04/16/2003 | CN1410453A Technology of refining chitin and its polychitose from silkworm skin |
| 04/16/2003 | CN1105780C Method for preparing poly dispersed saccharide composition and resulting poly dispersed saccharide composition |
| 04/16/2003 | CN1105752C Composite konjak glue and its preparing method |
| 04/15/2003 | US6548081 Hyaluronic acid derivative is an N-acylurea that results from crosslinking hyaluronic acid with a multifunctional carbodiimide. reducing post-operative adhesion of tissues. |
| 04/10/2003 | WO2003029297A2 Method and device for producing modified polysaccharide-based oligomers |
| 04/10/2003 | WO2003028781A1 Glycosaminoglycan-polycation complex crosslinked by polyfunctional crosslinking agent and process for producing the same |
| 04/10/2003 | WO2003008489A3 Composition and process for inhibiting corrosion of metallic substrates |
| 04/10/2003 | WO2003000178A3 Black soybean polysaccharides |
| 04/10/2003 | WO2003000118A3 Method for enhancing the effectiveness of cancer therapies |
| 04/10/2003 | US20030069206 Chitosan; packaging; and instructions indicating that the chitosan may be consumed with food for reducing absorption of lipids by the digestive system |
| 04/10/2003 | US20030069205 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 04/10/2003 | US20030068429 Inulin products with improved nutritional properties |
| 04/10/2003 | CA2461906A1 Method and device for producing modified polysaccharide-based oligomers |
| 04/09/2003 | EP1300412A1 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 04/09/2003 | EP1299424A1 COLD WATER SOLUBLE $g(b)-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 04/09/2003 | EP1171234B1 A novel agropolymer used for purification of polluted water or contaminated water containing metal or ions and a method of producing the agropolymer |
| 04/09/2003 | EP0986580B1 Oligosaccharide mixtures having antithrombotic activity |
| 04/09/2003 | CN1408730A Method for effectively reducing chlorine gas produced while bleaching gracilaria verrucosa with sodium hypochlorite |
| 04/09/2003 | CN1408729A Process for preparing non-derivative low deacetylation water soluble chitin |
| 04/08/2003 | US6545145 In human and animal foods |
| 04/08/2003 | US6545136 Process for producing desulfated polysaccharide, and desulfated heparin |
| 04/08/2003 | US6544964 Cyclodextrin derivatives in which at least one of the hydroxy groups has been methylated whilst the other hydroxy groups may be modified by methyl groups or other groups, for complexing lead ions. |
| 04/03/2003 | WO2003027304A1 Processes for producing inulin |
| 04/03/2003 | WO2003026793A2 Crosslinked three-dimensional polymer network, method for preparing same, support material comprising same and uses thereof |
| 04/03/2003 | WO2003026677A1 Pharmaceutical composition comprising chito-oligomers |
| 04/03/2003 | US20030065167 Process for preparing a directly compressible beta-cyclodextrin, and directly compressible beta-cyclodextrin thus obtained |
| 04/03/2003 | US20030064960 Medicine for inducing osteogenesis |
| 04/03/2003 | US20030064484 Process of preparing biologically active substance |
| 04/02/2003 | EP1124896B1 Method for preparing smooth-surface spherical microparticles completely or partially made of at least one water-insoluble linear polysaccharide |
| 04/02/2003 | EP1045863B1 Detoxication of active pharmaceutical substances using cyclodextrine oligomers |
| 04/02/2003 | EP0859795B1 Process for making crystalline iron dextran |
| 04/02/2003 | EP0830380B1 Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof |
| 04/02/2003 | CN1104504C Process for preparing amylovorin of sea bacteria |
| 04/01/2003 | US6541614 Polysaccharide derivative |
| 04/01/2003 | US6541587 Saccharide-derived monomer, method for manufacturing the same and highly-dielectric polymer consisting of the said monomer |
| 04/01/2003 | CA2163539C N-morpholino-n-nitrosaminoacetonitrile cyclodextrin inclusion complexes |
| 03/27/2003 | WO2003025280A1 Method for separating hemicelluloses out of biomass that contains hemicelluloses |
| 03/27/2003 | WO2003025133A2 Methods of making glycolmolecules with enhanced activities and uses thereof |
| 03/27/2003 | WO2003025022A1 Method of extracting chitin from the shells of exoskeletal animals |
| 03/27/2003 | WO2003024984A1 Novel oxime-linked polysaccharides and methods of preparing the same |
| 03/27/2003 | US20030060610 Method of extracting chitin from the shells of exoskeletal animals |
| 03/27/2003 | US20030060518 Process for producing glucomannan gel particles |
| 03/27/2003 | US20030060449 Nutraceuticals for treatment of leukemia and solid tumors |
| 03/27/2003 | US20030060446 Polycondensation of mono-/di-/tri- glycerides; for use in paper manufacturing and drug delivery vehicles |
| 03/27/2003 | US20030057159 Of microcrystalline chitosan; involves precipitation of dissolved chitosan from an acid solution by the step-wise addition of neutralizing agent |
| 03/27/2003 | CA2459040A1 Methods of making glycolmolecules with enhanced activities and uses thereof |
| 03/26/2003 | EP1294920A2 Deesterified pectins, processes for producing such pectins, and stabilized acidic liquid systems comprising the same |
| 03/26/2003 | EP1294774A1 Soluble carob |
| 03/26/2003 | EP1294773A2 Low methoxyl pectins, processes thereof, and stabilized aqueous systems comprising the same |
| 03/26/2003 | EP1294750A2 Acid-modified arabinogalactan protein composition |
| 03/26/2003 | EP1294355A1 Use of inulin and inulin derivatives |
| 03/26/2003 | EP1294354A1 Use of inulins and inulin derivatives |
| 03/26/2003 | EP1265931A4 Production of cyclodextrin complexes |
| 03/26/2003 | EP1140960A4 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| 03/26/2003 | CN1405187A Cucurbitacin cyclodextin inclusion compound and preparation thereof |
| 03/26/2003 | CN1103784C Process for the preparation of alky lated cyclodextrin derivatives, the products prepared by the process and the use of the products |
| 03/25/2003 | US6538117 Linear sequence of three or more glycosyl units linked to one another by glycosidic linkages; database of reactivity values for glycosyl donors |
| 03/25/2003 | US6537979 Water-insoluble derivatives of hyaluronic acid crosslinked with a biscarbodiimide |
| 03/25/2003 | US6537795 Supercapsulated mutated strain of streptococcus from culture medium free of metal ions |
| 03/25/2003 | CA2075681C Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide |
| 03/20/2003 | WO2003022887A1 Substances made of modified polysaccharides and method for the production thereof |
| 03/20/2003 | WO2003022291A1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 03/20/2003 | WO2003004536A3 Method for producing cross-linked polysaccharides and use thereof as stationary phases in separation processes |
| 03/20/2003 | WO2002092131A3 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
| 03/20/2003 | WO2002075042A3 Method for separating hemicelluloses from a biomass containing hemicelluloses |
| 03/20/2003 | WO2001073104A9 Beta-glucans from filamentous fungi |
| 03/20/2003 | US20030055211 Anionic polyelectrolyte; may be mixed with other water soluble anionic polyelectrolyte, especially sodium alginate, to form admixtures or blends from which films, fibers, powders, gels sponges can be prepared |
| 03/20/2003 | US20030055023 Injectable formulation of a sedative hypnotic drug, such as the anesthetic drug etomidate, that is pharmaceutically stable, demonstrates a reduced incidence of pain upon injection |
| 03/20/2003 | US20030054963 Mixing fast-hydrating high-viscosity guar powder to hydrating liquid to prepare well-treating fluid, hydrating guar powder, mixing cross-linker to well-treating fluid, introducing well-treating fluid to wellbore |
| 03/20/2003 | US20030052426 Forming spherical droplets by mechanical means dividing a polysaccharide solution, conveying through a humid atmosphere and transferred to a capturing water medium |
| 03/19/2003 | EP1292315A2 Methods and compositions using sulodexide for the treatment of diabetic nephropathy |
| 03/19/2003 | EP1292314A2 Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of glycosaminoglycans |
| 03/19/2003 | EP1272531A4 Crystalline mixtures of partial methyl ethers of beta-cyclodextrin and related compounds |
| 03/19/2003 | EP1194453B1 Stabilizer for pharmacons |
| 03/19/2003 | EP1137671B1 Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions |
| 03/19/2003 | EP0980262B1 Solid pharmaceutical formulations containing a physical mixture of sulfoalkyl ether cyclodextrin and a therapeutic agent |
| 03/19/2003 | CN1404497A Fast hydrating dispersible biopolymer |
| 03/19/2003 | CN1403485A Pectin oligosaccharide and its prepn process and application in preventing and treating plant diseases |
| 03/19/2003 | CN1103339C Process for producing medicinal-grade peat sodium fulvic acid |
| 03/18/2003 | US6534648 Isolated algal lipopolysaccharides and use of same to inhibit endotoxin-initiated sepsis |
| 03/18/2003 | US6534647 Surface-active alkylurethanes of fructans |
| 03/18/2003 | US6534591 First and second polymers containing nucleophilic groups and electrophylic groups capable of reacting to form covalent bonds between polymers, resulting in formation of three-dimensional matrix |
| 03/18/2003 | US6534481 Antithrombin III binding domain consisting of a concatenation of five monosaccharides supporting a total of two carboxylic acid functions and at least four sulpho groups, said domain being directly bound at the non-reducing end by a thrombin |
| 03/18/2003 | US6534294 Glucose:glucosamine copolymer wherein glucosamine is present at mole percent in range of between about 5 and about 65 percent |
| 03/13/2003 | WO2003020771A1 Chitosan-thio-amidine conjugates and their cosmetic as well as pharmaceutic use |
| 03/13/2003 | WO2003020735A1 Saccharide sulfation methods |
| 03/13/2003 | WO2003020296A1 INHIBITION OF ANGIOGENESIS AND DESTRUCTION OF ANGIOGENIC VESSELS WITH EXTRACTS OF NONI JUICE $i(MORINDA CITRIFOLIA) |
| 03/13/2003 | WO2001097848A3 Vitronectin receptor antagonist pharmaceuticals |
| 03/13/2003 | US20030050279 Beta-glucans |
| 03/13/2003 | US20030050278 Agent and food for inhibiting IgE antibody |
| 03/12/2003 | EP1291363A1 Pectin, process for producing the same, acidic protein foods with the use of the same and process for the production thereof |